D3A
Benign neuroendocrine tumors
Codes in this block
27 codes
Billableusable codeNon-billableheader / grouping codeRisk-adjusting
- D3ABenign neuroendocrine tumorsNon-billable
- D3A.0Benign carcinoid tumorsNon-billable
- D3A.00Benign carcinoid tumor of unspecified siteBillable
- D3A.01Benign carcinoid tumors of the small intestineNon-billable
- D3A.010Benign carcinoid tumor of the duodenumBillable
- D3A.011Benign carcinoid tumor of the jejunumBillable
- D3A.012Benign carcinoid tumor of the ileumBillable
- D3A.019Benign carcinoid tumor of the small intestine, unspecified portionBillable
- D3A.02Benign carcinoid tumors of the appendix, large intestine, and rectumNon-billable
- D3A.020Benign carcinoid tumor of the appendixBillable
- D3A.021Benign carcinoid tumor of the cecumBillable
- D3A.022Benign carcinoid tumor of the ascending colonBillable
- D3A.023Benign carcinoid tumor of the transverse colonBillable
- D3A.024Benign carcinoid tumor of the descending colonBillable
- D3A.025Benign carcinoid tumor of the sigmoid colonBillable
- D3A.026Benign carcinoid tumor of the rectumBillable
- D3A.029Benign carcinoid tumor of the large intestine, unspecified portionBillable
- D3A.09Benign carcinoid tumors of other sitesNon-billable
- D3A.090Benign carcinoid tumor of the bronchus and lungBillable
- D3A.091Benign carcinoid tumor of the thymusBillable
- D3A.092Benign carcinoid tumor of the stomachBillable
- D3A.093Benign carcinoid tumor of the kidneyBillable
- D3A.094Benign carcinoid tumor of the foregut, unspecifiedBillable
- D3A.095Benign carcinoid tumor of the midgut, unspecifiedBillable
- D3A.096Benign carcinoid tumor of the hindgut, unspecifiedBillable
- D3A.098Benign carcinoid tumors of other sitesBillable
- D3A.8Other benign neuroendocrine tumorsBillable
Official Guidelines for D3A
FY 2026 ›I.C.2Chapter-specific guidanceChapter 2: Neoplasms (C00-D49)
Subsections
- I.C.2.aAdmission/Encounter for treatment of primary site
- I.C.2.bAdmission/Encounter for treatment of secondary site
- I.C.2.cCoding and sequencing of complications
- I.C.2.dPrimary malignancy previously excised
- I.C.2.eAdmissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy
- I.C.2.fAdmission/encounter to determine extent of malignancy
- I.C.2.gSymptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms
- I.C.2.hAdmission/encounter for pain control/management
- I.C.2.iMalignancy in two or more noncontiguous sites
- I.C.2.jDisseminated malignant neoplasm, unspecified
- I.C.2.kMalignant neoplasm without specification of site
- I.C.2.lSequencing of neoplasm codes
- I.C.2.mCurrent malignancy versus personal history of malignancy
- I.C.2.nLeukemia, Multiple Myeloma, and Malignant Plasma Cell
- I.C.2.oAftercare following surgery for neoplasm
- I.C.2.pFollow-up care for completed treatment of a malignancy
- I.C.2.qProphylactic organ removal for prevention of malignancy
- I.C.2.rMalignant neoplasm associated with transplanted organ
- I.C.2.sBreast Implant Associated Anaplastic Large Cell Lymphoma
- I.C.2.tSecondary malignant neoplasm of lymphoid tissue